Corpus Intelligence IC Memo — CLEVELAND CLINIC AVON HOSPITAL 2026-04-26 10:38 UTC
IC Memo — CLEVELAND CLINIC AVON HOSPITAL
Investment Committee Memorandum | OH | 126 beds | Grade C | EBITDA uplift $13.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CLEVELAND CLINIC AVON HOSPITAL

CCN 360364 | CUYAHOGA, OH | 126 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CLEVELAND CLINIC AVON HOSPITAL is a 126-bed suburban community hospital in CUYAHOGA, OH with $178.3M in net patient revenue and a 16.3% operating margin. The hospital serves a payer mix of 33.4% Medicare, 1.7% Medicaid, and 64.9% commercial.

Thesis: Turnaround. Our ML models identify $13.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.3% to 23.7% (+736bps).

Net Revenue HCRIS$178.3M
Current EBITDA COMPUTED$29.1M
Operating Margin COMPUTED16.3%
Occupancy HCRIS60.7%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS26.9%
Distress Probability ML44.7%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
95
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 16.3% places it above the state median. Among 95 size-comparable peers (63-252 beds), the median margin is 0.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (63-252), prioritizing same-state peers. 95 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CLEVELAND CLINIC AVON HOSPITAL (Target)OH126$178.3M16.3%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
ADENA REGIONAL MEDICAL CENTEROH209$470.7M3.5%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%
SOUTHWEST GENERAL HEALTH CENTEOH191$406.9M2.5%
MEDCENTRAL HEALTH SYSTEMOH240$382.6M0.2%
MARION GENERAL HOSPITALOH177$365.7M35.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $13.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.7M+210bp18mo
Cost to Collect4.5%2.5%$3.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.2M+122bp9mo
Clean Claim Rate88.0%96.0%$114K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.7M
Cost to Collect
$3.6M
Denial Rate Reduction
$3.5M
A/R Days Reduction
$2.2M
Clean Claim Rate
$114K
Total EBITDA Uplift$13.1M
Current EBITDA$29.1M
+ RCM Uplift+$13.1M
Pro Forma EBITDA$42.2M
Current Margin16.3%
Pro Forma Margin23.7%
WC Released (1x)$6.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$44.8M$323.3M7.22x48.5%
Base (11x exit)10.0x11.0x$44.8M$370.2M8.26x52.6%
Bull Case9.0x11.0x$40.3M$428.0M10.62x60.4%
Bull (12x exit)9.0x12.0x$40.3M$478.9M11.88x64.0%
Bear Case11.0x10.0x$49.3M$243.1M4.93x37.6%
Bear (11x exit)11.0x11.0x$49.3M$283.4M5.75x41.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 95 hospitals with 63-252 beds
  • Same-state prioritization (n=96)
  • Comp margins: P25=-12.7% / P50=0.2% / P75=7.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.